 |
Northeast Georgia Health System Medical Staff PodcastAuthor: Northeast Georgia Health System, Inc.
CME and Medical Staff Podcasts Language: en-us Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
NGMC Medical Staff Podcast, Episode 13: Pulmonology
Friday, 19 June, 2026
Hosted by Larry Dudas, MD and Dan Robinson, MDGuests for today's episode:Vijaya Ramalingam, MD, FCCPPulmonary and Critical Care Physician, NGPGProgram Director, Pulmonary and Critical Care Medicine Fellowship, NGMC Stefanie Kananda, DONortheast Georgia Physicians Group Pulmonology Disclosures: NoneClaim CME Credit: https://www.surveymonkey.com/r/W88KJD3 Post Date: 6/1/26Expiration Date: 6/1/28 Accreditation Statement: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. If you have technical difficulties or questions contact CME@nghs.comAMA citationsAnzueto A, Barjaktarevic IZ, Siler TM, et al. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials). Am J Respir Crit Care Med. 2023;208(4):406-416. doi:10.1164/rccm.202306-0944OC Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med. 2024;390(24):2274-2283. doi:10.1056/NEJMoa2401304 Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS). Respir Med. 2025;236:107846. doi:10.1016/j.rmed.2024.107846 Sciurba FC, Criner GJ, Christenson SA, et al. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype. N Engl J Med. 2025;392(17):1710-1720. doi:10.1056/NEJMoa2413181
